To verify the treatment mechanism of CD51+ bMSCs in acute MI, we collected the infarcted hearts at 3 days post-cellular transplantation to test the expression of IL-1β by immunofluorescence staining and flow cytometry analysis. This evidence concerns the gene ITGAV and myocardial infarction.